Access our Data Analysis Report for Oncology

Our team has created a sample report based on data published from a study from Genentech, Inc. that Fios Genomics has been involved in. This study, investigating response to PD-L1 blockade therapies in patients with metastatic urothelial cancers, has been published in Nature (Mariathasan et al. Nature 2018).

The report presents a portion of the published analysis above concerning overall survival and response to treatment. We highlight the ability of high-throughput approaches to define biomarkers which accurately predict both treatment response to anti-PD-L1 therapy and overall survival in patients with metastatic urothelial cancer.

Fios Difference

Fios Genomics offers established, cost-efficient and rapid turnaround analysis services for gene expression data from a range of platforms.

Every time our clients work with Fios, they benefit from:  

• A dedicated analyst backed by an experienced team to curate all data, identify the most appropriate statistical approach to take, and provide a biological interpretation of results. 
• An interactive data analysis report, internally peer-reviewed, including all analysis methods and results.  
• Post-report follow-ups: upon receipt of our data analysis report, we arrange a teleconference so that our lead analyst can talk through the results. 
• Access to large capacity computing and secure data storage facilities. 

Fill out this form to access our

data analysis sample report